Recent Updates
Recently added Catalysts
LIVN Positive Sentiment

LivaNova to Present at Goldman Sachs Global Healthcare Conference in June 2026

Key Takeaway: LivaNova PLC announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference scheduled for June 8, 2026. CEO Vladimir Makatsaria, CFO Alex Shvartsburg, and Chief Strategy Officer Phil Kowalczyk will engage in a fireside chat. The event will be available via webcast, with a replay accessible shortly after.
Price reaction · baseline $72.23 (2026-05-18 close) · hit pre-market · 1 other LIVN headline(s) in the window, move may be shared
day 0 close · peak
+1%

Market Sentiment Analysis

POSITIVE FACTORS

  • LivaNova is participating in a prestigious healthcare conference.
  • The event will feature key executives discussing company strategies.
  • The webcast will be accessible to a wide audience.

Full Press Release Details

LONDON--(BUSINESS WIRE)--$LIVN#OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the Goldman Sachs 47thAnnual Global Healthcare Conference in Miami Beach, Fla. Vladimir Makatsaria, Chief Executive Officer of LivaNova; Alex Shvartsburg, Chief Financial Officer; and Phil Kowalczyk, Chief Strategy and Corporate Development Officer, will participate in a fireside chat on Mon., June 8, 2026, at 8 a.m. Eastern Daylight Time.
The discussion will be available to all interested parties who register to attend the webcast, which is accessible viawww.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper setup of the webcast. A replay will be available on the LivaNova website within 24 hours after the live presentation.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a vision to change the trajectory of lives for a new day. Through ingenious medical solutions in select neurological and cardiac conditions, LivaNova strives to ignite patient turnarounds. Headquartered in London, with approximately 3,300 employees and a presence in more than 100 countries, LivaNova serves patients, healthcare professionals, and healthcare systems worldwide. For more information, please visitwww.livanova.com.
Safe Harbor Statement
This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding participation in upcoming events. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.
LivaNova Investor Relations and Media Contacts

Frequently Asked Questions

When will LivaNova present at the conference?

LivaNova will present on June 8, 2026, at 8 a.m. EDT.

Who will represent LivaNova at the conference?

CEO Vladimir Makatsaria, CFO Alex Shvartsburg, and Phil Kowalczyk will participate.

How can I access the conference webcast?

The webcast can be accessed by registering at www.livanova.com/events.

Will there be a replay of the presentation?

Yes, a replay will be available on the LivaNova website within 24 hours.

Last updated: May 19, 2026